Showing results (21-30 of 49) with videos related to
Sort By:
Pageof 5
Psycho-Oncology|May 22, 2015
Social support and its implications in older, early-stage breast cancer patients in CALGB 49907 (Alliance A171301)Aminah Jatoi, Hyman Muss, Jake B Allred, et al.Annals of Surgical Oncology|July 24, 2020
Cosmetic Outcomes Following Breast-Conservation Surgery and Radiation for Multiple Ipsilateral Breast Cancer: Data from the Alliance Z11102 StudyKari M Rosenkranz, Karla Ballman, Linda McCall, et al.Annals of Surgical Oncology|July 11, 2018
The Feasibility of Breast-Conserving Surgery for Multiple Ipsilateral Breast Cancer: An Initial Report from ACOSOG Z11102 (Alliance) TrialKari M Rosenkranz, Karla Ballman, Linda McCall, et al.Chest|September 11, 2010
Number of lymph nodes harvested from a mediastinal lymphadenectomy: results of the randomized, prospective American College of Surgeons Oncology Group Z0030 trialGail E Darling, Mark S Allen, Paul A Decker, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 11, 2013
End points and trial design in geriatric oncology research: a joint European organisation for research and treatment of cancer--Alliance for Clinical Trials in Oncology--International Society Of Geriatric Oncology position articleHans Wildiers, Murielle Mauer, Athanasios Pallis, et al.Breast Cancer Research and Treatment|October 13, 2019
A pooled analysis of the cardiac events in the trastuzumab adjuvant trialsEvandro de Azambuja, Noam Ponde, Marion Procter, et al.The Journal of Thoracic and Cardiovascular Surgery|February 22, 2011
Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non-small cell carcinoma: results of the American College of Surgery Oncology Group Z0030 TrialGail E Darling, Mark S Allen, Paul A Decker, et al.Urologic Oncology|March 21, 2020
Prognostic value of the SPOP mutant genomic subclass in prostate cancerJonathan Shoag, Deli Liu, Xiaoyue Ma, et al.Cancer Research|May 20, 2016
Improved Survival of HER2+ Breast Cancer Patients Treated with Trastuzumab and Chemotherapy Is Associated with Host Antibody Immunity against the HER2 Intracellular DomainKeith L Knutson, Raphael Clynes, Barath Shreeder, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 2, 2025
Adjuvant Dose-Dense Chemotherapy in Hormone Receptor-Positive Breast CancerOtto Metzger Filho, Karla Ballman, Jordan Campbell, et al.Pageof 5